XOMA Royalty (XOMA) Share-based Compensation Growth (3y) (2013 - 2026)
XOMA Royalty (XOMA) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
4.80% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
13.26% |
| Date | Value |
|---|
| Mar 31, 2026 |
13.26% |
| Dec 31, 2025 |
58.24% |
| Sep 30, 2025 |
29.98% |
| Jun 30, 2025 |
-50.75% |
| Mar 31, 2025 |
26.57% |
| Dec 31, 2024 |
7.53% |
| Sep 30, 2024 |
49.25% |
| Jun 30, 2024 |
51.87% |
| Mar 31, 2024 |
-0.49% |
| Dec 31, 2023 |
56.43% |
| Sep 30, 2023 |
56.56% |
| Jun 30, 2023 |
40.92% |
| Mar 31, 2023 |
-4.24% |
| Dec 31, 2022 |
30.79% |
| Sep 30, 2022 |
-18.59% |
| Jun 30, 2022 |
-6.10% |
| Mar 31, 2022 |
-17.28% |
| Dec 31, 2021 |
37.59% |
| Sep 30, 2021 |
-2.75% |
| Jun 30, 2021 |
-0.09% |
